Inventor · disambiguated record
Sara Vasan
Also filed as: VASAN SARA
11 granted patents·16 pending applications·363 citations·filing 1995–2009
93Inventor score
Top patents by PatentIndex Score
27 records- 0192US5853703APreventing and reversing the formation of advanced glycosylation endproductsPICOWER INST MED RES·Filed 1996·Granted Dec 29, 1998·116 cites·86 claims
- 0289US6007865AReversing the formation of advanced glycosylation endproductsALTEON INC·Filed 1997·Granted Dec 28, 1999·51 cites·45 claims
- 0387US6440749B1Method of treating certain indications associated with hyperglycemiaALTEON INC·Filed 1999·Granted Aug 27, 2002·48 cites·55 claims
- 0486US5656261APreventing and reversing advanced glycosylation endproductsPICOWER INST MED RES·Filed 1995·Granted Aug 12, 1997·69 cites·57 claims
- 0585US7166625B2Method for treating fibrotic diseases and other indicationsALTEON INC·Filed 2001·Granted Jan 23, 2007·14 cites·8 claims
- 0680US7022719B2Preventing and reversing the formation of advance glycosylation endproductsALTEON INC·Filed 2003·Granted Apr 4, 2006·7 cites·5 claims
- 0780US6319934B1Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compoundsALTEON INC·Filed 2000·Granted Nov 20, 2001·11 cites·15 claims
- 0879US6790859B2Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compoundsALTEON INC·Filed 2003·Granted Sep 14, 2004·9 cites·21 claims
- 0975US6121300AReversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium saltsFiled 1998·Granted Sep 19, 2000·29 cites·57 claims
- 1067US7432254B2Method for treating glaucoma ICSYNVISTA THERAPEUTICS INC·Filed 2001·Granted Oct 7, 2008·2 cites·16 claims
- 1164US2009124674A1Method for treating congestive heart failureSYNVISTA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1264US2009124673A1Method for treating diabetic nephropathySYNVISTA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1364US2008132553A1Preventing and reversing the formation of advance glycosylation endproductsCERAMI ANTHONY·Filed 2007·Application pending·0 cites
- 1461US2007043016A1Method of treating fibrotic diseases or other indications with imidazolium agentsWAGLE DILIP R·Filed 2006·Application pending·0 cites
- 1559US2007025926A1Preventing and reversing the formation of advance glycosylation endproductsCERAMI ANTHONY·Filed 2006·Application pending·0 cites
- 1659US2004235837A1Method for treating fibrotic diseases or other indications IEFiled 2004·Application pending·0 cites
- 1758US2003176426A1Method for treating fibrotic diseases or other indications with imidazolium agentsALTEON INC·Filed 2003·Application pending·0 cites
- 1854US2002192842A1Method of treating certain indications associated with hyperglycemiaFiled 2002·Application pending·0 cites
- 1952US2008241840A1Methods of detection using immuno-Q-Amp technologyQ RNA INC·Filed 2007·Application pending·0 cites
- 2051US2006014781A1Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein agingWAGLE DILIP R·Filed 2005·Application pending·0 cites
- 2150US2002160992A1Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium saltsFiled 2001·Application pending·0 cites
- 2250US2004198795A1Substituted imidazoliums and methods of use thereforWAGLE DILIP R·Filed 2004·Application pending·0 cites
- 2348US2008220449A1Biomarkers and assays for Alzheimer's diseaseOLIGOMERIX INC·Filed 2008·Application pending·0 cites
- 2447US2006199194A1Methods of detection using immuno-Q-Amp technologyQ RNA INC·Filed 2005·Application pending·0 cites
- 2545USRE38330EPreventing and reversing advanced glycosylation endproductsALTEON INC·Filed 1999·Granted Nov 25, 2003·7 cites·234 claims
- 2645US2007218491A1Oligomerization of amyloid proteinsOLIGOMERIX INC·Filed 2007·Application pending·0 cites
- 2742US2006257904A1Agglomeration protein cascades, compositions and methods regarding the sameQ RNA INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sara Vasan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →